null result

  1. SNT Gatchaman

    Trial Report Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover Trial, 2026, Stortz et al.

    Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover Trial BACKGROUND Post-Covid syndrome is a debilitating condition which may be caused and/or aggravated by autoantibodies. The current study aimed to determine whether autoantibody depletion...
  2. Nightsong

    [Abstract] Efficacy of Low-Dose Naltrexone for Fibromyalgia: [double blind placebo RCT] With 12 Months of Follow-Up, 2026, Luciano et al

    Poster abstract from the EULAR rheumatology conference - EFFICACY OF LOW-DOSE NALTREXONE FOR FIBROMYALGIA: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL WITH 12 MONTHS OF FOLLOW-UP (Luciano et al., 2026) Low-Dose Naltrexone Fails to Outperform Placebo for Pain in Fibromyalgia Treatment...
  3. forestglip

    Preprint Effect of Percutaneous Auricular Nerve Stimulation on Fatigue in Adults with Post-COVID Fatigue (PAuSing-pCF): [...], 2026, Shahmandi et al

    Effect of Percutaneous Auricular Nerve Stimulation on Fatigue in Adults with Post-COVID Fatigue (PAuSing-pCF): Results of a Randomised, Sham-Controlled Trial Background Post-COVID fatigue (pCF) affects 2.3% of the UK population and causes physical and mental fatigue, impacting daily life...
  4. SNT Gatchaman

    Transcutaneous Auricular Vagal Nerve Stimulation Against Fatigue Syndrome in Patients with Long COVID…, 2026, Gierthmuehlen+

    Transcutaneous Auricular Vagal Nerve Stimulation Against Fatigue Syndrome in Patients with Long COVID: Results of the Randomized, Placebo-Controlled Clinical Pilot Trial COVIVA INTRODUCTION Fatigue is the most prevalent symptom in “long COVID”, affecting 6–7% of patients after COVID-19...
  5. SNT Gatchaman

    Feasibility and preliminary effects of a yoga program developed for adults with [LC]: pilot randomized controlled trial, 2026, Welfordsson+

    Feasibility and preliminary effects of a yoga program developed for adults with post COVID-19 condition Breathe Easy: pilot randomized controlled trial INTRODUCTION Effective medical management of post COVID-19 condition (post COVID) remains challenging. Symptoms are heterogenous...
  6. Hutan

    Trial Report The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID, 2026, Reis et al

    The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID Abstract Abstract Background and Objective: Postacute sequelae of SARS-CoV-2, or long COVID, presents a major therapeutic challenge, with fatigue being a prevalent and debilitating symptom. Objective: To assess...
  7. SNT Gatchaman

    Cognitive and Neuropsychiatric Sequelae After SARS-CoV-2 Infection: A Narrative Review and Exploratory [Study of NfL & GFAP], 2026, Priego+

    Cognitive and Neuropsychiatric Sequelae After SARS-CoV-2 Infection: A Narrative Review and Exploratory Cross-Sectional Study of Neurofilament Light Chain and GFAP BACKGROUND Persistent cognitive and neuropsychiatric symptoms have been increasingly reported as part of the post-COVID-19...
  8. SNT Gatchaman

    Paxlovid shows organ-specific and age-specific impacts on risk of developing post-acute sequelae of COVID-19, 2026, Azhir et al.

    Paxlovid shows organ-specific and age-specific impacts on risk of developing post-acute sequelae of COVID-19 BACKGROUND The impact of antiviral therapies, including Paxlovid, on post-acute sequelae of COVID-19 (PASC) remains inconclusive. METHODS We analyzed data from 19,413 patients (age >...
  9. J

    Preprint Autoantibody landscapes in neurological Long COVID and post-COVID cognitive impairment show heterogeneity without a shared disease signature Chakravar

    Abstract Background: Neurological Long COVID (n-LC) includes persistent cognitive and autonomic symptoms after SARS-CoV-2 infection. Prior studies of post-COVID conditions have described diverse humoral autoreactivity, but findings are heterogeneous, and it remains unclear whether n-LC is...
  10. SNT Gatchaman

    Preprint A phase 2a double-blind, placebo-controlled randomized trial of the SARS-CoV-2-specific monoclonal antibody AER002…, 2026, Peluso+

    A phase 2a double-blind, placebo-controlled randomized trial of the SARS-CoV-2-specific monoclonal antibody AER002 in people with Long COVID Long COVID is a disabling chronic illness with no proven treatments. Persistence of SARS-CoV-2 has been proposed as a biological driver of the disease...
  11. Dolphin

    Stretching exercises or walking did not produce clinically meaningful improvements in quality of life of patients with fibromyalgia,2026, Pontes-Silva

    https://www.sciencedirect.com/science/article/abs/pii/S0211563826000015 Fisioterapia Available online 2 March 2026 In Press, Corrected ProofWhat’s this? Original A. Pontes-Silva, M.A. Avila https://doi.org/10.1016/j.ft.2026.01.001Get rights and content Abstract Overview Considering that...
  12. SNT Gatchaman

    Treatment effects of multimodal inpatient psychotherapy for post-COVID patients: First results from a non-randomized, controlled study, 2026, Koller+

    Treatment effects of multimodal inpatient psychotherapy for post-COVID patients: First results from a non-randomized, controlled study BACKGROUND Evidence-based treatment options for post-COVID syndrome remain limited. This study evaluated the effectiveness of a five-week inpatient...
  13. SNT Gatchaman

    Trial Report Neither Metformin nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae of COVID-19, 2026, Lim et al.

    Neither Metformin nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae of COVID-19 BACKGROUND There is no proven treatment to alleviate symptoms of postacute sequelae of SARS-CoV-2 infection (PASC), despite its substantial public health burden. OBJECTIVE To evaluate the efficacy of...
  14. SNT Gatchaman

    Preprint Exploratory analyses of Immunologic Features in a Randomized, Placebo-Controlled Trial of Nirmatrelvir/Ritonavir for [LC], 2026,Bhattacharjee,Iwasaki+

    Exploratory analyses of Immunologic Features in a Randomized, Placebo-Controlled Trial of Nirmatrelvir/Ritonavir for Long COVID This exploratory analysis of PAX LC, a Phase 2, 1:1 randomized, double-blind, superiority, placebo-controlled trial examined whether treatment with...
  15. Utsikt

    The causal status of pain catastrophizing: an experimental test with healthy participants, 2005, Severeijns et al

    The causal status of pain catastrophizing: an experimental test with healthy participants Severeijns, Rudy; van den Hout, Marcel A.; Vlaeyen, Johan W.S. Abstract In the current study we report findings on the effects of experimentally induced catastrophizing about pain on expected pain...
  16. Chandelier

    Is long-term disruption of the renin-angiotensin-aldosterone system associated with LC?A retrospective cohort study healthcare workers,2026,Lange-Tal

    Full title: Is long-term disruption of the renin-angiotensin-aldosterone system associated with long COVID? A retrospective cohort study among healthcare workers https://link.springer.com/article/10.1186/s12879-026-12527-z Previous link that required a login...
  17. Andy

    Chronic Reactivation of Persistent Human Herpesviruses EBV, HHV-6 and VZV and Heightened Anti-dUTPase IgG Antibodies... 2025 Ariza et al

    Full title: Chronic Reactivation of Persistent Human Herpesviruses EBV, HHV-6 and VZV and Heightened Anti-dUTPase IgG Antibodies Are a Recurrent Hallmark in Post-Infectious ME/CFS and is Associated With Fatigue ABSTRACT Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a...
  18. Utsikt

    Trial Report Effectiveness of a group-based self-management program for people with chronic fatigue syndrome: a randomized controlled trial, 2016, Pinxsterhuis et

    Effectiveness of a group-based self-management program for people with chronic fatigue syndrome: a randomized controlled trial Abstract Objective: To evaluate the effectiveness of a group-based self-management program for people with chronic fatigue syndrome. Design: A randomized controlled...
  19. J

    Evaluation of Interventions for Cognitive Symptoms in Long COVID, 2025, Knopman et al

    https://recovercovid.org/news/recover-neuro-clinical-trial-shares-results-three-non-drug-treatments-cognitive-symptoms-long In other words, didn’t work.
  20. SNT Gatchaman

    Trial Report Effectiveness of Colchicine for the Treatment of Long COVID: A Randomized Clinical Trial, 2025, Bassi et al.

    Effectiveness of Colchicine for the Treatment of Long COVID: A Randomized Clinical Trial IMPORTANCE Long COVID is characterized by persistent symptoms after SARS-CoV-2 infection, with inflammation playing a key role in pathogenesis. Colchicine, an established anti-inflammatory agent, may...
Back
Top Bottom